CSU study: Lack of gene patents unlikely to damage biotech industry


Last week’s Supreme Court decision that human genes cannot be patented may not have the dire consequences some in the biotechnology industry fear, according to a study led by Greg Graff, Colorado State University associate professor of Agricultural and Resource Economics.